Brought to you by:
Deadline extension: SAVS extends travel scholarship application cut-off for 2023 meeting
The Southern Association for Vascular Surgery (SAVS) has announced a deadline extension to Dec. 5 for 20 travel scholarships that are available to medical students and general surgery residents to attend the 2023 SAVS annual meeting (Jan. 18–21). Half of…
VAM 2023: Apply for international scholars program by Dec. 31
Young vascular surgeons from outside the United States and Canada have until Dec. 31 to apply for scholarships to attend the 2023 Vascular Annual Meeting (VAM). VAM will be held June 14–17, 2023, in National Harbor, Maryland, just outside Washington,…
Spotlight: SVS members in the news
Several SVS members have been making moves recently, attracting recognition in the form of awards and promotions. Katherine Gallagher, MD, of the University of Michigan, has been elected to the National Academy of Medicine for her “innovative translational research on…
Viz.ai announces positive new data from large aortic dissection AI real-world study
Viz.ai recently announced new data from a large aortic dissection artificial intelligence (AI) real-world study that supports the use of its AI technology for the detection of suspected aortic dissection. Data from the new study, which were presented this week at VEITHsymposium 2022…
First-in-human patients continue to benefit from VenoValve at average of three years post-surgery, new data show
Positive long-term, three-year observational data from a cohort of patients that participated in the previously concluded VenoValve (Envveno Medical) first-in-human clinical trial were recently presented at the VEITHsymposium 2022 (Nov. 15–19) in New York City. Principal investigator Jorge Hernando Ulloa, MD,…
Complete SVS member priorities survey by Nov. 22
To help the Society for Vascular Surgery (SVS) chart a path into the future, members—and non-members alike—are asked to complete an ongoing survey by Nov. 22. The survey is to help SVS better understand members’ and non-members’ perception of top…
SWING trial 12-month data: Novel sirolimus DCB shows ‘great promise’ in ‘challenging’ CLTI population
The Sundance (Surmodics) sirolimus drug-coated balloon (DCB) has an “excellent” safety profile in a “challenging, real-world, predominantly CLTI [chronic limb-threatening ischemia] population,” and has a primary patency rate of 80% at 12 months in a per-protocol analysis population. Ramon Varcoe,…
VEITHsymposium panel probes ‘value’ of artificial intelligence in vascular surgery
A session at the 2022 VEITHsymposium in New York City (Nov. 15–19) focused on new concepts, machine learning, and artificial intelligence (AI) in vascular surgery, with a panel discussion honing in on the cost-effectiveness and wider “value” of emerging technologies…
The top 10 most popular Vascular Specialist stories of October 2022
The most-read Vascular Specialist stories in October covered an investigation of thoracic endovascular aortic repair (TEVAR) timing presented at the Eastern Vascular Society (EVS) meeting in Philadelphia (Sept. 29–Oct. 1); the editor-in-chief’s open letter to the National Rifle Association; tips on…
Veterans Day: Remembering Korea, ‘accidental pioneers’ and M*A*S*H
During November—Nov. 11, specifically—the United States salutes and honors all those who have served this country in its armed forces. This November, the Society for Vascular Surgery (SVS) highlights the Korean War, where vascular surgeons typically served in Mobile Army…